In recent times, additional pathways involved in the regulation of the myometrium have been suggested. This also holds true for the effect of drugs such as oxytocin (OT) and b-adrenergic agonists on the myometrium. Knowledge of these additional pathways will certainly prove useful in designing better therapies for pathologies of the myometrium. This study was therefore aimed at investigating the possibility of other pathways involved in the activities of both OT and ritodrine (RIT; a b-adrenergic agonist) in the myometrium by utilizing metabolomics and bioinformatics. High-resolution Fourier transform mass spectrometry (HRFTMS) and nuclear magnetic resonance (NMR) spectroscopy coupled with functional uterine assays were used for an innovative assessment. In vitro pharmacological assay of OT (1 nmol/L) and RIT (0.1 nmol/L) on isolated mice uteri mounted in 3 mL organ baths was performed. Mice uteri, treated with OT or RIT, as well as the physiological buffer in which the uterine tissues were immersed, were rapidly collected and analyzed using HRFTMS, proton ( 1 H)-NMR, and bioinformatics. Resulting data were analyzed via pairwise chemometric comparison models, with P .05 considered statistically significant. In addition to previously known metabolites, nicotinamide adenine dinucleotide, g-aminobutyric acid, and sphingosine were significantly associated with the activity of OT, whereas the activity of RIT was associated with a downstream involvement of prostaglandin F 1 and phosphatidylinositol signaling. These findings add evidence to the reports on additional regulation of myometrial activity by these drugs and suggest newer pathways for therapeutic manipulation.
Introduction
The uterus has been described as ''the poor sister among isolated tissues in the pharmacologist's armamentarium'' because it is difficult to work with. 1, 2 This difficulty has created gaps in our current understanding of uterine function and associated pathologies in both the pregnant (eg, preterm birth) and nonpregnant states (endometriosis). Comprehensive studies on uterine metabolite profiling appear to be sparse. The need for increased comprehension of myometrial metabolites perturbed during uterine contractility and/or inhibition is therefore essential to aid in the development of effective treatments and early diagnosis of myometrial pathologies in a bid to counter prevailing reproductive health issues. The important roles played by metabolites in smooth muscle cells cannot be overemphasized. The use of new techniques such as metabolomics shows great potential in improving the current knowledge on uterine functioning and has therefore been employed in this study.
Oxytocin (OT) is a known uterine contraction stimulant, and ritodrine (RIT) a b-adrenergic agonist is a known uterine relaxant, however, some molecular and cellular mechanisms underlying OT-induced modulation of uterine contractility are not completely understood. 3 Oxytocin is one of the most potent uterotonic agents known, and its effect on uterine contractility is of major clinical importance. It is known that OT generates inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol (DAG) 4 by binding to its cell surface transmembrane receptor (OTR). 5 In attempting to increase the understanding of myometrial contractility, it is equally important to note that membrane potentials also play key roles. In the nonpregnant uterus, the resting membrane potential hovers around À70 mV. 6 Should pregnancy occur, a progressive decline is observed, eventually reaching values of about À55 mV at parturition. 6 These changes are necessary for intense contractions to occur during labor. 7 Utilizing the signal effectors mentioned above, OT has been reported to lengthen the duration and increase the frequency of action potentials in the myometrium. 8 Together these effects increase mobilization and utilization of calcium 7 via the store-operated channels regulated by metabolites such as IP 3 and ryanodine. 9 Through a cascade of activity, IP 3 and DAG metabolites independently mediate the release of Ca 2þ from intracellular stores and promote myometrial contraction. 10 This pathway is considered the major pathway that mediates OTR signal after binding with OT and for a long time was considered the only pathway. 10 However, recent reports state that new pathways involved in OT activity on the myometrium are emerging. 11 For instance, it was recently reported that OTR activates mitogen-activated protein kinase (MAPK) and the Rho kinase pathways resulting in increased cytosolic phospholipase A 2 and subsequently increased prostaglandin production via the cyclooxygenase (COX) pathway. 12, 13 The COX pathway specifically COX-2 is also upregulated by MAPK. 13, 14 On the other hand, RIT, via b 2 -adrenoceptor activation, is known to activate adenosine triphosphate-activated potassium (K ATP ) channels and large conductance potassium (BKCa) channels in the myometrium through cyclic adenosine monophosphate (cAMP)-dependent phosphorylation and/or directly via guanosine triphosphate (GTP) metabolite. 15 This pathway had been thought to be majorly involved in the inhibitory effect of RIT on the myometrium. Yet, studies by 2 separate groups found poor association of these channels with the effect of RIT on myometrial inhibition. 16, 17 This therefore lends further support to the possibility of yet unknown mediators associated with the activity of RIT. Nonetheless, RIT is occasionally used in the clinics for myometrial relaxation in preterm labor. 18, 19 Metabolites are functional units released within cells in response to signals. Measurement of these metabolites can therefore provide increased understanding into the basic mechanisms of several metabolic actions. 20 The key technologies in metabolomics include high-resolution Fourier transform mass spectrometry (HRFTMS) and 1-dimensional (1D)/2-dimensional (2D) nuclear magnetic resonance (NMR). These technologies enable the detection and identification of several spectral features used in mapping out potentially significant metabolites responsible for a number of biological activities. 21, 22 Sampling during metabolomic analysis measurement can include biofluids and/or tissues, and in such instances, the tissue samples can be used to investigate specific information related to the tissue or organ, while the study of biofluids can be used to predict the metabolic changes that have occurred in an animal's organs. 23 By extrapolation, the bath fluid used to conduct in vitro experiments should contain metabolites that have been released from the tissues that reflect the functional state of the tissue at that time. These metabolites can either support findings from the tissue or add additional information about metabolites that may have gone undetected in the tissue. Incorporating metabolomic analysis therefore will further aid in the determination of other pathways involved in the activity of RIT or OT on the myometrium. The innovative use of metabolomics coupled with pharmacological assay has never been applied previously. As a proof of principle, however, Shah and colleagues identified a number of proteins (desmoplakin isoform 1, stratifin, and thrombospondin 1) as potential preterm birth protein biomarkers from cervical-vaginal fluids. 24 In this study, we report the use of pharmacology coupled with metabolomic methods for the characterization of metabolite alterations in the mouse myometrium that have occurred in response to OT and RIT. This study also attempts to identify additional pathways involved in myometrial regulation that can be manipulated for therapeutic purposes.
Materials and Methods
All experiments were carried out in accordance with the Animal Health and Welfare (Scotland) Act 2006 and the Public Health Service Policy on Humane Care and Use of Laboratory Animals 2002.
Animals
Female virgin C57BL/6 strain laboratory mice weighing between 19 and 25 g were used in this study. The animals were obtained from the Biological Procedures Unit of the University of Strathclyde, United Kingdom. Mice were maintained in a controlled environment with temperatures maintained at 25 C and the room conditioned to 60% relative humidity. Mice were also maintained under a 12/12-hour cycle of light and dark and had free access to food and water. Mice in proestrus and estrus states were selected via microscopic smear examination and macroscopic (visual) examination for these experiments. Selected animals were euthanized under rising concentration of CO 2 . The animals were immediately exsanguinated prior to the excision of the uterine tissues. Four animals were used for each set of experiments.
Contractility Experiments
The dissected uteri were cut into segments of approximately 0.5 to 0.8 cm in longitudinal length, cleaned of extra connective tissues to provide 4 preparations per mouse. The segments were then weighed and subsequently mounted in warmed (37 C) 3 mL organ baths containing normal Krebs-Henseleit physiological solution composed of 118.4 NaCl, 25 NaHCO 3 , 11.1 glucose, 4.69 KCl, 2.41 MgSO 4 , 1.18 KH 2 PO 4 , 2.5 CaCl 2 (mmol/L), and continuously bubbled with carbogen (95% O 2 , 5% CO 2 ). Tissues were loaded with an initial tension of 1 g, equilibrated for 30 minutes before subsequent run of experiments and washed at a flow rate of 500 mL/min. The differential force and frequency of spontaneous contractions in the longitudinal muscle layer were recorded using Grass (ADInstruments, Australia) (FTO3) isometric force transducers connected via Quad (ADInstruments, Australia) Bridge modules to a PowerLab 4/20 data acquisition system using Chart 3.3 software (AD Instruments, United Kingdom) that was used to store and analyze acquired data.
Concentration-Response Studies
A uterine contractile agent (OT) and relaxant (RIT) of known mechanisms of action were used in this study. Both OT (1 nmol/L) and RIT (0.1 nmol/L) were added to the bath containing uterine tissues. The concentrations producing maximum response were determined from preliminary experiments. Maximum response was a prerequisite for this study in order to eliminate bias or doubts. For instance with RIT, it was necessary that complete inhibition was attained in order that metabolites specifically responsible for inhibition alone are measured. The same applies for OT. Single concentrations of OT and RIT were added to the bath for 10 minutes following stable rhythmic spontaneous contractions. Without washing, the uterine tissues were collected when the activity was at its peak and immediately flash frozen in liquid nitrogen. Flash freezing was achieved by rapidly lifting the tissues out of the organ bath and cutting the threads holding the uterine segments to the transducer and tissue holder. The tissues were placed into cryovials, immediately capped, and then immersed into liquid nitrogen. The whole procedure lasting approximately 30 seconds. Fast and efficient flash freezing is important, as it had been reported that cells/tissues remain responsive to their surrounding until physiologic measures are effected to prevent responses completely. 25, 26 The buffer (3 mL) that had contained the uterine tissue was similarly collected, placed into preweighed vials, and flash frozen. The uterine tissues and bath fluids, which remained untreated with either drug, were designated as controls. All samples were subsequently stored at À80 C prior to further experiments.
Metabolite Extraction
Materials for metabolite extraction. Deuterated dimethyl sulfoxide (DMSO-d 6 ) and chloroform (CDCl 3 ), high-performance liquid chromatography (HPLC) grade methanol, HPLC grade dichloromethane (DCM), OT, carbachol, RIT, verapamil, potassium chloride, DMSO were purchased from Sigma (United Kingdom). All drugs were prepared as stock solutions in distilled water, except for RIT, which was dissolved in DMSO.
Tissue metabolite extraction. Each flash-frozen tissue was homogenized using an ULTRA-TURRAX T8 homogenizer (IKA-WERKE GmbH & Co, Germany) in 400 mL methanol (MeOH), vortexed for 60 seconds before being centrifuged using a Force 7 (Fisher Scientific UK Limited, Leicestershire, United Kingdom) at 13 000 rpm/g for 5 minutes. The supernatant was collected using a micropipette syringe and formed the polar tissue extracts. The residue was extracted with 400-mL DCM, vortexed for 60 seconds, and centrifuged at 13 000 rpm/g for 10 minutes. The supernatant was also collected and formed the nonpolar tissue extracts. Wet homogenization combined with direct extraction has been described as one of the best methods for metabolite extraction from tissues as it gives one of the best metabolite reproducibility and improves the extraction process. 27 The whole procedure was performed in the cold with the aid of dry ice. The periods used were predetermined from preliminary experiments. The supernatant was collected using a micropipette syringe and dried in preweighed vials in preparation for further NMR and mass spectrometry (MS) measurements.
Extraction of metabolites released into the buffer solution (bath fluids). Buffer samples (bath fluids) were freeze-dried and weighed. The dried samples were reconstituted in 500 mL of MeOH and vortexed for 1 minute. The solution of the mixture was pipetted out and centrifuged as previously described. The supernatant was collected and named polar fluid extracts. The residue was reconstituted in 600 mL of DCM and followed procedures as described for the tissues to form the nonpolar fluid extracts. Again, all procedures were performed in the cold with the aid of dry ice.
Mass spectrometry data acquisition. The MeOH extracts (both tissue and fluid) were separately reconstituted in 100% MeOH, whereas the DCM extracts were reconstituted in DCM-MeOH at a ratio of 30:70 determined from preliminary experiments as suitable for dissolving the nonpolar extracts obtained in this study. Samples were transferred into auto-sampler MS vials containing 200 mL inserts for HPLC-MS analysis. The HPLC-HRFTMS analysis was carried out using a Dionex Ulti-Mate 3000 HPLC system (Thermo Fisher Scientific Inc, Hemel Hempstead, United Kingdom) with a 75.0 Â 3.0 mm C18 column (a silica type 5 mm C18 ACE HPLC column [HiChrom Limited, United Kingdom]). The column was eluted with a linear gradient of 90% A (0.1% vol/vol [v/v] formic acid in water) and 10% B (0.1% v/v formic acid in acetonitrile) mobile phases over 0 to 35 minutes. The flow rate was maintained at 0.3 mL/min throughout the run. After the first 35 minutes, the column was eluted with 100% B for a further 5-minute isocratic elution, and a return to starting conditions at 40 minutes. Reequilibration was performed at the last 5 minutes, giving a total of 45 minutes for the entire run. The MS identification and analyses were carried out using a Thermo Scientific Orbitrap-Exactive (Thermo Fisher Scientific Inc), with a 10-mL injection volume, and the MS was operated with UV detection at 254 nm using both positive and negative ion modes. Full-scan data were collected from 50 to 2000 mass to charge ratio (m/z), with a scan time of 0.1 seconds. Capillary and cone voltages were set at 3.5 kV and 35 V, respectively, desolvation and low controlled source temperatures were used.
High-resolution liquid chromatography-HRFTMS profiling. The highresolution liquid chromatography (HRLC)-HRFTMS metabolic profiles of polar and nonpolar OT-and RIT-treated tissues and surrounding bath fluids were analyzed before and after drug treatment. The resulting data were then preprocessed, and analysis was performed with the online metabolomic analysis program, XCMS (a liquid chromatography mass spectrometry data analysis program designed by the Scripps Research Institute, CA, USA). The raw liquid chromatography-MS data obtained were first sliced into positive and negative ion modes before conversion to mzXML files prior to XCMS processing. Identification of metabolites was performed within XCMS online using METLIN database. During processing, a novel nonlinear retention time alignment was performed. This is sequentially performed with matched filtration, peak detection, and peak matching. 28 Statistical determination was also performed at P < .05 for each pairwise comparison of control and drugtreated groups, with P < .01 considered highly significant.
The HRLC-HRFTMS data analysis. The XCMS peak areas were extracted and imported into the soft independent method of class analogy (SIMCA-P, version 13.0; Umetrics AB, Umeå, Sweden) for principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis (OPLS-DA). Statistical analyses based on a pairwise comparison of control and treated groups were acquired for the different drugs. Differentially regulated metabolites with P values <5% and fold change (FC) >150% were considered statistically significant and used for subsequent analyses. 29, 30 Prior to OPLS-DA modeling, the data were normalized using column centering and Pareto scaling (1= ffiffiffiffiffiffi SD p [standard deviation]) before modeling. 30, 31 A default sevenfold cross validation was performed on the OPLS-DA model to check for model overfitting, and this was determined from the diagnostic parameters R 2 Y (residual sum of squares of all y variables) and Q 2 Y (an estimate of the predictive ability of the model calculated by cross validation of all y variables). For visualization and interpretation, the OPLS-DA score scatterplots, S plots, and loading plots with confidence intervals were used. The jackknifed loading plot was additionally sorted by size in order to separate up-and downregulated metabolites at each end of the plots.
Bioinformatic analyses were subsequently performed on resulting data using the Ingenuity Pathway Analysis (IPA) tool (Ingenuity Systems, Redwood City, California) for the pathways search regulated by the identified metabolites. The IPAmetabolomics is a program within IPA that extracts rich pathway information from metabolomics data. Statistical significance was calculated using Fisher exact test, P < .05 indicated a statistically significant no-random association. For a given data set, IPA automatically generates the pathways that are related to those metabolites.
Proton NMR measurements. The dried MeOH extracts obtained from both tissue and fluid extraction processes described previously were weighed and reconstituted in DMSO (200 mL), vortexed for 30 seconds, and placed in Shigemi NMR tubes (5 mm) or capillary NMR inserts for 1D proton ( 1 H)-NMR measurements. Similarly, the DCM extracts were weighed and reconstituted in CDCl 3 (200 mL) and placed in Shigemi NMR tubes. Presaturated 1 H-NMR experiments were carried out on a JEOL-LA400 FT-NMR spectrometer system (JEOL Ltd, United Kingdom) with an AS400 magnet and for 1 H using a Pulse Field Gradient ''Autotune'' 40TH5AT/FG broadband high-sensitivity probe to accept 5 mm tubes. One-dimensional 1 H-proton with presaturation of the residual water resonance NMR spectra was obtained using the following parameters; 32 k data points, spectral width of 5998.4 Hz, an acquisition time of 2.73 seconds, a relaxation delay of 3.0 seconds, and pulse width of 5.47, requiring a 3.85-minute total acquisition time.
Nuclear magnetic resonance data preprocessing and analysis. All NMR data sets were preprocessed using Mnova version 8.1. The imported spectra were manually phased, apodized at Gaussian ¼ 1.0, and baseline corrected to Bernstein polynomial order fit (order 3). The spectra were binned between d0.5 and 9 ppm at bin value of d0.04 ppm width. Bins representing the residual water and solvent peaks were removed. The total spectra area was subsequently normalized to a total value of 100. This yielded a total of 163 and 165 contiguous data for the polar and nonpolar data sets, respectively. The resulting data yielded a 2D matrix (n Â d). The resulting data matrix was then exported into SIMCA-P software package (version 13.0; Umetrics AB). Mean centering was performed prior to the application of PCA and OPLS-DA to the acquired data sets. The biplot was used for visualization and interpretation of the NMR data. The S-line was also used to provide supporting information on the variables. It is similar to a statistical total correlation spectroscopy 32 and is particularly suitable for spectroscopy data. A color scale was also utilized for analysis, as it provides information about the chemical shifts of the data set and corresponding metabolites that contribute to the differences among groups. Biplots and S-lines derived from the OPLS-DA models are shown in Supplementary Figure 2 .
Proron NMR profiling. Superimposed pair-matched 1 H-NMR spectra of control versus treated mouse uterine tissues and respective bath fluids are presented in Supplementary Figure  6A to H. The spectral resolution of the 1D spectra and 2D proton correlation spectroscopy combined with reported data from the literature [33] [34] [35] [36] [37] [38] [39] [40] enabled the identification and assignment of different metabolites at varying chemical shift ranges. The Fourier induction decays were processed using Mnova version 8.1. Figure 1 is a schematic showing the various processes involved in this study.
Results

Effect of OT and RIT on Spontaneous Uterine Contractions
Oxytocin (1 nmol/L) increased the force and frequency of uterine contractions (Figures 2A and 3A) . The RIT (0.1 nmol/L), however, decreased contractility of spontaneously contracting tissues ( Figures 2B and 3B ). This process was necessary in order to observe and confirm the effect of the drugs on uterine contraction and to observe the effect at the time of tissue collection. 
Metabolomic Analyses
The XCMS processing yielded 17 154 and 9891 variables for polar (OT-treated polar tissues) and nonpolar OT-treated tissues (OT-treated nonpolar tissues), respectively, whereas 21 340 and 16 934 variables were acquired for polar (OT-treated polar bath fluids) and nonpolar OT treated fluids (OT-treated nonpolar bath fluids), respectively.
For polar (RIT-treated polar tissues) and nonpolar (RITtreated nonpolar tissues) RIT-treated tissues, 14 149 and 32 051 variables were, respectively, acquired, whereas 23 260 and 26 770 variables were acquired for polar (RIT-treated polar bath fluids) and nonpolar RIT-treated fluids (RIT-treated nonpolar bath fluids), respectively. These numbers included isotopic and adduct ion peaks.
Pathways common to both OT and RIT were extracted and found to include phosphatidylinositol signaling, niacinamide metabolism, cell signaling, DAG signaling, and glycerophospholipid and catecholamine metabolism ( Table 1) .
The OPLS-DA score plots showed distinct separations between the control and treated in all experimental groups. A summary of the parameters acquired for prediction and separation in the OPLS-DA models is shown in Supplementary  Tables 1 and 2 . An S-plot, which varies slightly from a scatter plot, was obtained and used to extract significant metabolites and to explain the contribution of the variables on the MS data ( Figure 3 ). From each of these plots, differentially significant metabolites were extracted using the jackknifed column plots arranged in descending order with fitted confidence intervals. Columns with confidence intervals that did not include 0 were considered significant ( Supplementary Table 3A for OT and 3B for RIT).
Metabolomic analysis of OT-treated uterine tissues and bath fluids.
Reliable models were derived with OPLS-DA for all OTtreated groups (R 2 ¼ 1.0), and the predictive ability was satisfactory, Q 2 > 0.4 in all cases ( Supplementary Tables 1 and 2) . The OPLS-DA plots showed distinct separations between all OT groups in this study (Figure 4) . Several significantly differential metabolites were detected to be either downregulated (negative sign) or upregulated (positive sign). Of interest were myoinositol (FC ¼ 1.980) and DAG (FC ¼ À5.989 and À1.264) in tissues and fluids, respectively. Also detected were nicotinic acid adenine dinucleotide phosphate (NADP; FC ¼ 2.858) and g-amino butyric acid (GABA; FC ¼ 5.847 and 2.952 in tissues and fluids, respectively). Tyrosine (FC ¼ 1.395), sphingosine (FC ¼ 2.213 and 1.678), N-arachidonylamine (AEA; FC ¼ À5.007), and several glycerophospholipids such as phosphatidylcholine (PC) with FC ¼ 2.175 and phosphatidylethanolamine (PE) with FC ¼ À3.937) were also detected on OT-treated myometrium ( Supplementary Table  3A ). These metabolites and corresponding pathways derived from the HRFTMS and 1 H-NMR are shown in Figures 5A to D and 6A, respectively. Myoinositol and DAG signaling were also detected through multivariate analysis of 1 H-NMR studies ( Figure 5 ) and biplots ( Supplementary Figure 2) .
Metabolomic analysis of RIT-treated uterine tissues and bath fluids.
Reliable predictive models were similarly derived for the OPLS-DA for all RIT-treated groups (R 2 ¼ 1.0; Q 2 > 0.4 in most cases; Supplementary Table 1A ). The OPLS-DA plots also showed distinct separations between all RIT groups in this study (Figure 4 ). Several significant differential metabolites were also detected by HRFTMS. Of interest were myoinositol (FC ¼ À13.582), AEA (FC ¼ 2.479), and prostaglandin F 1 (FC ¼ 17.764). Others included tyrosine (FC ¼ 4.078), PC with FC ¼ 15.263, and PE with FC ¼ 3.265 ( Supplementary  Table 3B ). Significant metabolites and corresponding pathways derived from the HRFTMS and 1 Bioinformatic analysis of OT-treated uterine tissues. Significant functions associated with OT-treated groups were lipid and carbohydrate metabolism, energy production, nucleic acid metabolism, and involvement in reproductive system function ; & ¼ phosphatidylinositol signaling system;~¼ ligand-receptor interaction/lipid metabolism (g-amino butyric acid; GABA); À ¼ cyclic adenosine monophosphate (cAMP) biosynthesis;ˆ¼ sphingolipid metabolism; ¿ ¼ cell signaling (arachidonic acid); OE ¼ nicotine/nicotinamide metabolism; Å ¼ glycine, serine, and threonine metabolism. The key metabolites that were perturbed are listed in Table 1 . n ¼ 5 animals.
( Figure 7 left panel) . Major pathways detected were myoinositol and DAG signaling ( Figure 8A -D left panel). Creation of a network of interacting and interrelated metabolites and corresponding pathways showed phosphatidylinositol, phosphatidylglycerol, and sphingosine pathways as significantly associated pathways (Figure 9 left panel) . Others included serotonin, nitric oxide (NO), and RhoGDI (ras homologous guanine diphosphate-dissociation inhibitor) signaling (Figure 9 left panel).
Bioinformatic analysis of RIT-treated tissues. Significant functions detected were cell signaling, lipid and carbohydrate metabolism, energy production, nucleic acid/amino acid metabolism, and involvement in reproductive system function (Figure 7 right panel). Pathways detected for RIT included myoinositol downregulation, DAG, and phosphate signaling as major pathways ( Figure 8A-D right panel) . A network of interacting metabolites and pathways showed cAMP-mediated signaling, protein kinase, and G-protein receptor signaling to be primarily involved with RIT-induced uterine relaxation (Figure 9 right panel).
Discussion
The observation in this study that myoinositol and AEA were among the statistically significant metabolites detected in the OT-treated myometrium correlates with previously documented activities reported on OT-induced uterine contraction. [41] [42] [43] [44] Myoinositol is a glucose derivative that functions in several signaling pathways, one of which is the phosphatidylinositol signaling pathway 45 activated by OT in the uterus. Other interesting findings in this study were the detection of NADP, GABA, and metabolites involved in pyrimidine/purine biosynthesis as well as metabolites involved in NO synthesis, some of which had not been previously associated with the action of OT on the uterus. Oxytocin has been associated with the inhibition of K þ -stimulated release of excitatory amino acids (glutamate and aspartate) in the supraoptic nerve via an indirect action on the terminals 19 but not in the myometrium. In this study, GABA was also found to have been released into the bath fluids in the presence of OT. The role of NADP as an alternative second messenger and an additional intracellular Ca 2þ store (besides the action of IP 3 on the sarcoplasmic reticulum during uterine contraction) is emerging. 46 This NADP component is coupled with the neurotransmitter glutamate, 47 which was a significant metabolite observed in this study. The NADP has also been reported to be linked with OT-induced contraction 1 in addition to cyclic ADP ribose acting on ryanodine receptors. 15 Another interesting finding was the decreased release of DAG from the tissues into the surrounding bath fluid observed in response to OT treatment. The simultaneous release of DAG in response to OT has been previously reported. 48 However, a study showed that inhibition of DAG release did not significantly suppress OT activity in the pregnant rat myometrium. 48 An implication that multiple mechanisms besides IP 3 and DAG exist in relation to the activity of OT on the myometrium. 4 These observations were similarly supported by the results of the 1 H-NMR data from the current study. Another interesting finding was the detection of downregulated AEA with FC equivalent to À2.337 on OT treatment. The AEA activates cannabinoid receptors that have been recently found expressed in reproductive tissues. 49 Binding of AEA to its receptors has been associated with the reduction and increase in intracellular cAMP levels, regulation of ion channels, and NO generation. 50 The AEA has been reported to cause both stimulatory and inhibitory effects on uterine contractility. 51, 52 Bioinformatic analysis in this study revealed an association of AEA with lipid metabolism during OT treatment. In this study, OT treatment increased AEA in tissues but decreased AEA in the surrounding bath fluids. An association between the lipids sphingosine and kynurenic acid, and OT activity was also detected. A relationship between OT, sphingosine, and the lysophospholipids has been previously described 14 but not in the myometrium. The action of RIT on spontaneous uterine activity generated several metabolites. In decreasing uterine contractility, RIT caused a downregulation of prostaglandin E 2 in the bath fluid. Bioinformatic analysis showed the upregulation of adenosine monophosphate (AMP) owing to the presence of pyrophosphates and kinases. A significant decrease in the concentration of myoinositol in comparison to OT treatment was also observed, suggesting a reduction in the phosphatidylinositol signaling pathway in the presence of RIT which supports recent studies linking cAMP signaling with phosphatidylinositol. 53, 54 The RIT treatment also decreased AEA concentration, DAG, and phenylalanine (a precursor of the catecholamines).
On examination of the 1 H-NMR spectra of polar RIT-treated tissues and bath fluids, the metabolites lactate, leucine, acetate, GABA, and glutamate were consistently observed, whereas the spectra of the nonpolar tissue and bath fluids showed the presence of hydroxybutyrate, leucine, lactate, acetate, GABA, and adenosine. The detection of adenosine suggests the involvement of cAMP with RIT. The OPLS-DA S-plots and biplots of both the MS and NMR data showed separations between RIT-treated tissues and controls. These plots also showed separations between RIT-treated bath fluids and controls. These marked separations indicate that differences in metabolites exist between both groups, which have resulted in the separation observed. 
Comparison of the Bioninformatic Profiles of Uterine Tissues and Surrounding Bath Fluids
Chemometric and bioinformatic analysis of the HRFTMS data revealed significant biologic functions for each group in this study. The OT treatment of tissues and bath fluids significantly altered functions such as lipid metabolism, carbohydrate metabolism, energy production, and small molecule biochemistry. Pathways altered by OT treatment included eicosanoid synthesis, incorporation of thymidine, and nucleotide synthesis, indicating an involvement of OT with these pathways. Treatment of uterine tissues with RIT affected the following functions: cell signaling, lipid metabolism, and small molecule biochemistry, while the RIT-treated fluids affected carbohydrate metabolism, energy production, small molecule biochemistry, and lipid metabolism. Of the significant pathways extracted for OT-treated tissues, TCA cycle, myoinositol biosynthesis, gluconeogenesis, and inositol triphosphate biosynthesis were upregulated. While of the significant pathways extracted for RIT-treated tissues, a downregulation of myoinositol biosynthesis, upregulation of GABA receptor signaling, gluconeogenesis, DAG biosynthesis, prostanoid biosynthesis, serotonin synthesis, and sphingosine metabolism were observed. In the bath fluids, however, OT induced an upregulation of creatinine phosphate and ceramide/ sphingosine biosynthesis. Overall, consistent pertubation of glycerophospholipid metabolism and lipid metabolism was involved in both relaxation and contraction of the uterus in response to drugs suggesting a role for these glycerophospholipids in the regulation of uterine contraction.
Examination of the bioinformatics networks indicated a strong association of OT with myoinositol, inositol triphosphate, and DAG. The involvement of other pathways such as sphingosine, serotonin, and NO were also dominant. Examination of the network indicated a strong association of RIT with a G-protein coupled receptor (possibly related to cAMP release and activation) and protein kinase A. In addition, a significant involvement of dopamine and ERK (extracellular signal-regulated kinase) signaling were detected and are suggested to be associated with myometrial bß-adrenoceptor activation.
Several similarities exist between the mouse and human myometrium, with a few minor differences in outcome. For instance, while decidualization occurs in humans and not in mice, the hormonal requirements for decidualization as well as the cell behaviors during the process are similar. 55 Again, due to the similarities between the human and mouse myometrium, several mouse models of reproductive health pathologies have been developed to assist in understanding the pathologies and development of suitable treatment, and these have been reviewed. 56 It will therefore be reasonable to assume that the novel pathways and functions associated with the effect of OT and RIT on the mouse myometrium may occur similarly in the human myometrium. It is, however, advised that further confirmatory studies be performed on the human myometrium in order to arrive at a more definite insight.
Conclusion
The detection of phosphatidylinositol and DAG pathways in connection with the activity of OT on the uterus as well as the detection of AMP, adenosine, and components involved in the cAMP pathway in connection with the effect of RIT on the uterus validates the sensitivity of this method in the detection of metabolites associated with drug function. The discovery of the involvement of other metabolites such as sphingosine and AEA with the activity of OT and the association of GABA and AEA with the activity of RIT provides a knowledge-based hypothesis for further research.
